Agilent Technologies, Inc. (A) Stock Score, Valuation & Financial Research
Agilent Technologies, Inc. is in the Healthcare sector and Medical - Diagnostics & Research industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 41/100.
Quick answer for A
Agilent Technologies, Inc. currently has a Wall Street Score of 41/100. The stored market price is $146.93. Its financial score is 39/100. Its valuation score is 16/100. The latest WSS change is +0.9 points. These figures are a research snapshot, not a buy or sell recommendation.
What Agilent Technologies, Inc. does
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and mic
A financial snapshot
- Wall Street Score:
- 41/100
- Current price:
- $146.93
- Market capitalization:
- $41.50B
- Revenue:
- $7.37B
- Net income:
- $1.44B
- Free cash flow:
- $1.15B
- Cash:
- $1.76B
- Total debt:
- $3.95B
- EPS:
- 5.09
- P/E ratio:
- 28.9x
- Financial score:
- 39/100
- Valuation score:
- 16/100
- Revenue score:
- 20/100
What stands out
- Reported year-over-year revenue growth is +0.1%.
- Free cash flow is $1.15B, showing positive cash generation.
- The balance sheet shows $1.76B of cash versus $3.95B of total debt, so leverage deserves attention.
- The latest Wall Street Score change is +0.9 points: A increased 0.9 points because Capital improved by 2 points, Valuation improved by 7.4 points.
What the numbers mean
Its current valuation score is 16/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 39/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-08.
How to research A
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.